Is filgotinib one of the safest Jak inhibitors for ulcerative colitis? Probably, according to the results from the Selection trial released late yesterday. Is it one of the most effective? Not so much, an opinion confirmed by the 6% share price slide in Galapagos stock this morning.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,